PNC-27
Studied for: membrane-targeting peptide
PNC-27 is a synthetic peptide combining a segment of the HDM-2-binding domain of p53 with a membrane-penetrating sequence. Research examines its binding to HDM-2 displayed on the membranes of cancer cells in culture, studied for transmembrane pore formation and cell necrosis.
How it is thought to work
Research investigates PNC-27 for binding the p53-binding region of HDM-2 present in cancer-cell membranes, studied for pore formation, mitochondrial membrane disruption and selective necrosis in cell models.
- HDM-2 BindingStudied for recognition of membrane-associated HDM-2, which research reports at higher levels on cancer cells than on normal cells.
- Pore FormationExplored for a helix-coil-helix conformation in membrane environments associated with transmembrane pore formation.
- Membrane-Level ActionStudied for activity at the cell membrane reported in cell lines of varying p53 status.
- Route studied
- Subcutaneous
Studies
Cited research
Citations pending review. We add PubMed references once each one has been checked against the source.
Ask about PNC-27
Plain answers from our library: the science, the studied ranges and our products. It can be wrong, and it does not give medical advice.
AI answers can be wrong. Research use only.